Randomized, double-blind, and multicenter phase II trial of rh-endostatin plus dacarbazine versus dacarbazine alone as first-line therapy for the patients with advanced melanoma.
Jun Guo
No relevant relationships to disclose
Chuan Liang Cui
No relevant relationships to disclose
Kangsheng GU
No relevant relationships to disclose
Min Tao
No relevant relationships to disclose
Song Xin
No relevant relationships to disclose
Tongyu Lin
No relevant relationships to disclose
Xiu Bao Ren
No relevant relationships to disclose
Shukui Qin
No relevant relationships to disclose